Exagen
30 hedge funds and large institutions have $14.1M invested in Exagen in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$842K | |
| 2 | +$424K | |
| 3 | +$97.3K | |
| 4 |
Renaissance Technologies
New York
|
+$78.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$35.9K |
Top Sellers
| 1 | -$923K | |
| 2 | -$118K | |
| 3 | -$31.8K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$16.7K |
| 5 |
BlackRock
New York
|
-$16K |